A Study of Hydrogen Peroxide-Generating E-bandage Safety
- Conditions
- Healthy
- Interventions
- Device: e-Bandages
- Registration Number
- NCT05940207
- Lead Sponsor
- Mayo Clinic
- Brief Summary
A novel hydrogen peroxide-generating electrochemical bandage for wound infection treatment and prevention, and wound healing has been developed. The purpose of this research is to gather information on the safety and to confirm lack of toxicity of small hydrogen peroxide-generating e-bandages on normal human skin.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 20
- Healthy.
- Intact skin on arms.
- Able to provide appropriate consent.
- Vulnerable study population.
- Pregnancy.
- Children.
- Skin disease.
- Non-intact skin on arms.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description e-Bandages 3 hours e-Bandages Three subjects will wear the e-Bandage on their skin for 3 hours. e-Bandages 6 hours e-Bandages Three subjects will wear the e-Bandage on their skin for 6 hours. e-Bandages 12 hours e-Bandages Three subjects will wear the e-Bandage on their skin for 12 hours. e-Bandages 24 hours e-Bandages Three subjects will wear the e-Bandage on their skin for 24 hours.
- Primary Outcome Measures
Name Time Method e-Bandage Discomfort Approximately 3 - 24 hours Self-report discomfort with the e-Bandage, graded on a scale of 1-4, with 1 being no reaction, 2 mild reaction, 3 moderate reaction, 4 severe reaction.
Skin irritation/dermatitis Approximately 3 - 24 hours Skin redness or swelling, graded on a scale of 1-4, with 1 being no reaction, 2 mild reaction, 3 moderate reaction, 4 severe reaction.
Allergic Reaction Approximately 3 - 24 hours Local/systemic allergic reaction to the e-Bandage, graded on a scale of 1-4, with 1 being no reaction, 2 mild reaction, 3 moderate reaction, 4 severe reaction.
Skin Discoloration Approximately 3 - 24 hours Skin discoloration from the e-Bandage, graded on a scale of 1-4, with 1 being no reaction, 2 mild reaction, 3 moderate reaction, 4 severe reaction.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mayo Clinic Minnesota
🇺🇸Rochester, Minnesota, United States